Preliminary Anatomical and Neurodevelopmental Outcomes of Intravitreal Bevacizumab As Adjunctive Treatment for Retinopathy of Prematurity

ARAZ-ERSAN, Bilge; Kir, Nur; Tuncer, Samuray; Aydinoglu-Candan, Ozlem; Yildiz-Inec, Dilbade; Akdogan, BASRİ; Ekici, Baris; Demirel, Atalay; Ozmen, Meral

doi:10.3109/02713683.2014.941070

Preliminary Anatomical and Neurodevelopmental Outcomes of Intravitreal Bevacizumab As Adjunctive Treatment for Retinopathy of Prematurity

ARAZ-ERSAN B., Kir N., Tuncer S., Aydinoglu-Candan O., Yildiz-Inec D., Akdogan B., ...Daha Fazla

CURRENT EYE RESEARCH, cilt.40, sa.6, ss.585-591, 2015 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 40 Sayı: 6
Basım Tarihi: 2015
Doi Numarası: 10.3109/02713683.2014.941070
Dergi Adı: CURRENT EYE RESEARCH
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.585-591
Anahtar Kelimeler: Antivascular endothelial growth factor, bevacizumab, retinopathy of prematurity, ENDOTHELIAL GROWTH-FACTOR, INJECTION, SAFETY, AVASTIN, BAYLEY, CHILD, ROP
İstanbul Üniversitesi Adresli: Evet

Özet

Purpose: To evaluate the two-year follow-up of patients with type 1 retinopathy of prematurity (ROP) who received intravitreal bevacizumab (IVB) as adjunctive treatment.